Antioxidant Protection: Helps protect the skin from environmental damage
The Phase 2 trial published in the New England Journal of Medicine in 2023 provides the clearest picture of its effects
Based on these findings, Novo Nordisk decided to study liraglutide not only as a diabetes drug but also as a potential treatment for obesity
Roger: You touched on the elephant in the room, Bret, and that is that, quite tragically the unmet need
However, if your goal is sustainable, long-term weight management, research consistently supports ongoing treatment
Patients with type 2 diabetes face a significantly higher risk of atrial fibrillation, yet GLP-1 receptor agonists are rarely discussed in rhythm management conversations